Want to learn more? Check out our

IIH Awareness Month Community Chat

September 8, 2023

In honor of Intracranial Hypertension (IIH) Awareness Month, we dedicated our September webinar to spotlight anyone who has IIH. We are so grateful for those who were able to attend our chat session and open up about their medical journey.

We hosted Ashley Carter who has battled with IIH for the past 3 years and is now well-controlled with Diamox. Dr. Pierre Gobin, a Neurointerventionalist from Weill Cornell in New York moderated the session and answered any medically-related questions. Dr. Brian Snelling, who is a neurosurgeon in South Florida, explained some of the current diagnostic tools and surgical treatment options for IIH.

Ashley Carter

Patient Advocate

A fashionista, creative, and writer, who’s journey with IIH began three years ago. Ashley became her own healthcare advocate, educating herself on IIH and papilledema and sharing her journey from diagnosis to treatment.

Read more about her story.

Dr. Y. Pierre Gobin

Interventional Neuroradiologist, Weill Cornell Medicine, New York and CEO, Serenity Medical

Dr. Y. Pierre Gobin is an interventional neuroradiologist at Weill Cornell Medicine in New York. He is a pioneer in new and effective treatments for cerebral aneurysms and has developed and established minimally invasive surgical approaches to treat acute strokes and eye tumors.

Idiopathic Intracranial Hypertension (IIH) is an underdiagnosed and undertreated disorder of elevated pressure within the brain without an identifiable cause. The IIH Practioner Series is designed for neurologists, neurosurgeons, neuro-interventionalists, endovascular surgeons, interventionist radiologists, neuroradiologists, ophthalmologists, optometrists, and ENT specialists.

Sponsored by

Novel neurovascular therapies for idiopathic intracranial hypertension (IIH)

Like what you are seeing?

Join our next webinar.

Thank you! You’re registration is complete for:

IIH Practitioner Series

Join our June webinar to discuss GLP1’s and its impact on patients with obesity.

June 24 at 9:30 am ET